Hot Line Trials of the European Society of Cardiology 2024 Congress

 

 

Hot Line 1: Friday 30th August, 11:00 – 12:09

11:00: HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy 

• Presenter TBC

11:22: ABYSS - Beta blocker interruption in post-myocardial infarction patients

• Johanne Silvain (Sorbonne University - Paris, France)

11:47: STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial 

• Matthieu Legrand (University of California at San Francisco - San Francisco, United States of America)

 

Hot Line 2: Saturday 31st August, 08:15 – 09:46

8:15: The BedMed and BedMed-Frail randomised controlled trials - Effect of antihypertensive timing on mortality and morbidity 

• Scott Garrison (University of Alberta - Edmonton, Canada)

8:30: Meta-analysis of trials of antihypertensive medication bedtime dosing including individual-patient data from BedMed and BedMed-Frail 

• Ricky Turgeon (University of British Columbia - Vancouver, Canada)

8:54: GMRx2 - Efficacy and safety of a novel triple single pill combination

• Anthony Rodgers (The George Institute for Global Health - Sydney, Australia)

9:09: QUADRO - A single 4-drug combination in hypertension 

• Stefano Taddei (University of Pisa - Pisa, Italy)

9:21: VERONICA - Nigeria - deliVERy of Optimal blood pressure coNtrol in afrICA

• Dike Bevis Ojji (University of Abuja - Abuja, Nigeria)

 

Hot Line 3: Saturday 31st August, 11:00 – 12:06

11:00: Tri.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

• Erwan Donal (Hospital Pontchaillou of Rennes - Rennes, France)

11:22: MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

• Volker Rudolph (Heart and Diabetes Center NRW - Bad Oeynhausen, Germany)

11:44: RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure 

• Stefan Anker (Charite University Hospital - Berlin, Germany)

 

Hot Line 4: Saturday 31st August, 16:15 – 17:21

16:15: ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery 

• Jung-Min Ahn (Asan Medical Center - Seoul, Korea (Republic of))

16:37: SWEDEGRAFT - No-touch vein grafts in coronary artery bypass grafting 

• Stefan James (Uppsala University - Uppsala, Sweden)

16:29: The TIGHT-K trial - Potassium supplementation and the prevention of atrial fibrillation after cardiac surgery 

• Benjamin O'Brien (Deutsches Herzzentrum der Charité - Berlin, Germany)

 

Hot Line 5: Saturday 31st August, 17:35 – 18:41

17:35: POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI? 

• Dirk Jan van Ginkel (St Antonius Hospital - Nieuwegein, Netherlands (The))

17:57: NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation 

• Jacob Thomsen Loenborg (Copenhagen University Hospital - Copenhagen, Denmark)

18:19: RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis 

• Helene Eltchaninoff (University Hospital of Rouen - Rouen, France)

 

Hot Line 6: Sunday 1st September, 08:15 – 09:41

8:15: STEEER-AF - Stroke prevention and rhythm control therapy 

• Dipak Kotecha (University of Birmingham - Birmingham, United Kingdom of Great Britain & Northern Ireland)

8:40: OCEANIC-AF - Asundexian versus apixaban in patients with atrial fibrillation 

• Manesh Patel (Duke University Medical Center - Durham, United States of America)

9:16: EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary arthery disease 

• Gi-Byoung Nam (Asan Medical Center - Seoul, Korea (Republic of))

 

Hot Line 7: Sunday 1st September, 11:00 – 12:06

11:00: FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction 

• Scott Solomon (Brigham and Women's Hospital, Harvard Medical School - Boston, United States of America)

11:22: MRAs in HF - An individual patient data meta-analysis of randomised trials 

• Pardeep Jhund (University of Glasgow - Glasgow, United Kingdom of Great Britain & Northern Ireland)

11:44: FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials 

• Muthiah Vaduganathan (Brigham and Women's Hospital, Harvard Medical School - Boston, United States of America)

 

Hot Line 8: Sunday 1st September, 16:15 – 17:21

16:15: SCOFF - Fasting or no fasting before cardiac catherisation procedures 

• David Ferreira (John Hunter Hospital - Newcastle, Australia)

16:37: EARTH-STEMI - Complete vs. culprit-only revascularization in older STEMI patients 

• Gianluca Campo (University Hospital of Ferrara - Ferrara, Italy)

16:59: SENIOR RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial 

• Vijay Kunadian (Newcastle University - Newcastle-Upon-Tyne, United Kingdom of Great Britain & Northern Ireland)

 

Hot Line 9: Sunday 1st September, 17:35 – 18:36

17:35: GUARD-AF - ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals

• Renato Lopes (Duke University Medical Center - Durham, United States of America)

17:50: STROKESTOP II - Randomised systematic NT-proBNP and ECG screening for atrial fibrillation among 75 year-olds 

• Katrin Kemp Gudmundsdottir (Karolinska Institutet Danderyd Hospital - Stockholm, Sweden)

18:14: MIRACLE-AF - A Novel Model of IntegRAted Care of OLdEr Patients with Atrial Fibrillation in rural China 

• Minglong Chen (The First Affiliated Hospital of Nanjing Medical University - Nanjing, China)

 

Hot Line 10: Monday 2nd September, 11:00 – 12:06

11:00: SHAM-PVI - A randomised sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation 

• Rajdip Dulai (University College London - London, United Kingdom of Great Britain & Northern Ireland)

11:22: SUPPRESS-AF - The efficacy of low-voltage-area ablation on atrial tachyarrhythmias recurrence in patients with persistent atrial fibrillation 

• Masaharu Masuda (Kansai Rosai Hospital - Amagasaki, Japan)

11:44: CRABL-HF - Cryoballoon vs. Radiofrequency Ablation of AF in Patients with Heart Failure 

• Kengo Kusano (National Cerebral and Cardiovascular Center Hospital - Osaka, Japan)

 

Hot Line 11: Monday 2nd September, 13:45 – 14:45

13:45: OCCUPI - Optical coherence tomography-guided coronary intervention in patients with complex lesions 

• Kim Byeong-Keuk (Severance Cardiovascular Hospital, Yonsei University College of Medicine - Seoul, Korea (Republic of))

14:05: INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

• David Erlinge (Lund University - Lund, Sweden)

14:25: REC-CAGEFREE I - A noninferiority study of drug-coated balloon vs drug-eluting stent for de novo coronary artery lesions 

• Ling Tao (Xijing Hospital of the Fourth Military Medical University - Xi'an, China)

 

Hot Line 12: Monday 2nd September, 15:15 – 16:21

15:15: PROTEUS - A prospective randomised controlled trial evaluating the use of artificial intelligence in stress echocardiography

• Ross Upton (University of Oxford - Oxford, United Kingdom of Great Britain & Northern Ireland)

15:37: RAPIDxAI - Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department by expediting evidence to practice using artificial intelligence 

• Derek Chew (Victorian Heart Hospital - Melbourne, Australia)

15:59: WESTCOR-POC - Point of care versus centralised high-sensitivity cardiac troponin in the emergency department 

• Viola Thulin (Haukeland University Hospital - Bergen, Norway)